VPAG Commercial Clinical Trial Capacity and Capability Short-Term Funding Request

This was a Voluntary Scheme for Branded Medicines Pricing and Access (VPAG) call.

Health and Care Research Wales opened a rolling funding call to submit requests for short-term funding required to support the delivery of commercial pharmaceutical interventional research, where the cost will be incurred between 1 April 2025 until 31 March 2026.

The purpose of the funding is to bolster clinical trial capability, by increasing workforce capacity and infrastructure as well providing agility relevant to the set up and delivery of commercial clinical research. This investment must accelerate the delivery of commercial pharmaceutical interventional research for the measurable benefit of health and wealth in Wales.